0000919574-23-006304.txt : 20231114
0000919574-23-006304.hdr.sgml : 20231114
20231114103427
ACCESSION NUMBER: 0000919574-23-006304
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230930
FILED AS OF DATE: 20231114
DATE AS OF CHANGE: 20231114
EFFECTIVENESS DATE: 20231114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CAXTON CORP
CENTRAL INDEX KEY: 0001388551
IRS NUMBER: 222437619
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15293
FILM NUMBER: 231402507
BUSINESS ADDRESS:
STREET 1: 731 ALEXANDER ROAD
STREET 2: BUILDING 2, SUITE 500
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-419-1800
MAIL ADDRESS:
STREET 1: 731 ALEXANDER ROAD
STREET 2: BUILDING 2, SUITE 500
CITY: PRINCETON
STATE: NJ
ZIP: 08540
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
true
false
0001388551
XXXXXXXX
09-30-2023
09-30-2023
false
CAXTON CORP
731 Alexander Road
Building 2, Suite 500
Princeton
NJ
08540
13F HOLDINGS REPORT
028-15293
N
Heath Weisberg
Chief Compliance Officer
212-205-6805
/s/ Heath Weisberg
Princeton
NJ
11-14-2023
0
9
26321829
true
INFORMATION TABLE
2
infotable.xml
ACLARIS THERAPEUTICS INC
COM
00461U105
133387
19473
SH
SOLE
19473
0
0
ALLAKOS INC
COM
01671P100
111978
49329
SH
SOLE
49329
0
0
APOGEE THERAPEUTICS INC
COM
03770N101
265653
12472
SH
SOLE
12472
0
0
COMPASS THERAPEUTICS INC
COM
20454B104
170942
86773
SH
SOLE
86773
0
0
ELEVATION ONCOLOGY INC
COM
28623U101
14453
21813
SH
SOLE
21813
0
0
MOLECULAR TEMPLATES INC
COM NEW
608550208
864993
136866
SH
SOLE
136866
0
0
REZOLUTE INC
COM NEW
76200L309
1741036
1318967
SH
SOLE
1318967
0
0
SAVARA INC
COM
805111101
12525416
3313602
SH
SOLE
3313602
0
0
XERIS BIOPHARMA HOLDINGS INC
COM
98422E103
10493971
5641920
SH
SOLE
5641920
0
0